Screener
Castle Biosciences CSTL Goodwill
Goodwill at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
We had a single reportable segment consisting of a single operating segment where the operating segment and the single reporting unit were the same as of March 31, 2026 and December 31, 2025, where all goodwill was allocated. As of March 31, 2026 and December 31, 2025, our goodwill was $10.7 million. There were no accumulated impairments of goodwill as of March 31, 2026 or December 31, 2025.
Item 1. Financial Statements.
FAQ
- What is Castle Biosciences's goodwill?
- Castle Biosciences (CSTL) reported goodwill of $10.7M in Q1 2026.
- How has Castle Biosciences's goodwill changed year-over-year?
- Castle Biosciences's goodwill decreased by 0.0% year-over-year, from $10.7M to $10.7M.
- What does goodwill mean?
- The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.
Ask your AI about Castle Biosciences's goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude